BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 20391482)

  • 1. Excess mortality emerges after 10 years in an inception cohort of early rheumatoid arthritis.
    Radovits BJ; Fransen J; Al Shamma S; Eijsbouts AM; van Riel PL; Laan RF
    Arthritis Care Res (Hoboken); 2010 Mar; 62(3):362-70. PubMed ID: 20391482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years.
    Gabriel SE; Crowson CS; Kremers HM; Doran MF; Turesson C; O'Fallon WM; Matteson EL
    Arthritis Rheum; 2003 Jan; 48(1):54-8. PubMed ID: 12528103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The widening mortality gap between rheumatoid arthritis patients and the general population.
    Gonzalez A; Maradit Kremers H; Crowson CS; Nicola PJ; Davis JM; Therneau TM; Roger VL; Gabriel SE
    Arthritis Rheum; 2007 Nov; 56(11):3583-7. PubMed ID: 17968923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term mortality rate in rheumatoid arthritis patients with disease onset in the 1980s.
    Kapetanovic MC; Lindqvist E; Geborek P; Saxne T; Eberhard K
    Scand J Rheumatol; 2011 Nov; 40(6):433-8. PubMed ID: 21619489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is the disease course of rheumatoid arthritis becoming milder? Time trends since 1985 in an inception cohort of early rheumatoid arthritis.
    Welsing PM; Fransen J; van Riel PL
    Arthritis Rheum; 2005 Sep; 52(9):2616-24. PubMed ID: 16142762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic importance of low body mass index in relation to cardiovascular mortality in rheumatoid arthritis.
    Kremers HM; Nicola PJ; Crowson CS; Ballman KV; Gabriel SE
    Arthritis Rheum; 2004 Nov; 50(11):3450-7. PubMed ID: 15529378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic strategies in rheumatoid arthritis over a 40-year period.
    Kremers HM; Nicola P; Crowson CS; O'Fallon WM; Gabriel SE
    J Rheumatol; 2004 Dec; 31(12):2366-73. PubMed ID: 15570636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population-based mortality outcome of rheumatoid arthritis in females.
    Iacovino JR
    J Insur Med; 2002; 34(2):86-8. PubMed ID: 15305782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular death in rheumatoid arthritis: a population-based study.
    Maradit-Kremers H; Nicola PJ; Crowson CS; Ballman KV; Gabriel SE
    Arthritis Rheum; 2005 Mar; 52(3):722-32. PubMed ID: 15751097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality in rheumatoid arthritis: have we made an impact in 4 decades?
    Gabriel SE; Crowson CS; O'Fallon WM
    J Rheumatol; 1999 Dec; 26(12):2529-33. PubMed ID: 10606358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality and predictors of mortality in rheumatoid arthritis--a role for mannose-binding lectin?
    Troelsen LN; Garred P; Jacobsen S
    J Rheumatol; 2010 Mar; 37(3):536-43. PubMed ID: 20110521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating levels of tumor necrosis factor receptors are highly predictive of mortality in patients with rheumatoid arthritis.
    Mattey DL; Glossop JR; Nixon NB; Dawes PT
    Arthritis Rheum; 2007 Dec; 56(12):3940-8. PubMed ID: 18050238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of mortality in rheumatoid arthritis based on disease activity markers.
    Book C; Saxne T; Jacobsson LT
    J Rheumatol; 2005 Mar; 32(3):430-4. PubMed ID: 15742433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of mortality with disease severity in rheumatoid arthritis, independent of comorbidity.
    Navarro-Cano G; Del Rincón I; Pogosian S; Roldán JF; Escalante A
    Arthritis Rheum; 2003 Sep; 48(9):2425-33. PubMed ID: 13130461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in incidence and mortality in rheumatoid arthritis in Rochester, Minnesota, over a forty-year period.
    Doran MF; Pond GR; Crowson CS; O'Fallon WM; Gabriel SE
    Arthritis Rheum; 2002 Mar; 46(3):625-31. PubMed ID: 11920397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with TNF blockers and mortality risk in patients with rheumatoid arthritis.
    Jacobsson LT; Turesson C; Nilsson JA; Petersson IF; Lindqvist E; Saxne T; Geborek P
    Ann Rheum Dis; 2007 May; 66(5):670-5. PubMed ID: 17158824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients?
    Gonzalez A; Maradit Kremers H; Crowson CS; Ballman KV; Roger VL; Jacobsen SJ; O'Fallon WM; Gabriel SE
    Ann Rheum Dis; 2008 Jan; 67(1):64-9. PubMed ID: 17517756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years.
    Nicola PJ; Maradit-Kremers H; Roger VL; Jacobsen SJ; Crowson CS; Ballman KV; Gabriel SE
    Arthritis Rheum; 2005 Feb; 52(2):412-20. PubMed ID: 15692992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of congestive heart failure and ischemic heart disease to excess mortality in rheumatoid arthritis.
    Nicola PJ; Crowson CS; Maradit-Kremers H; Ballman KV; Roger VL; Jacobsen SJ; Gabriel SE
    Arthritis Rheum; 2006 Jan; 54(1):60-7. PubMed ID: 16385496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baseline levels of C-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis: a ten-year followup study of a primary care-based inception cohort.
    Goodson NJ; Symmons DP; Scott DG; Bunn D; Lunt M; Silman AJ
    Arthritis Rheum; 2005 Aug; 52(8):2293-9. PubMed ID: 16052597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.